“…Although the role of cysteinyl LTs in the inflammation of AD is unclear, several reports in the literature, but not all (Veien et al, 2005), detail improvements in patients (adult and children) with moderate to severe AD with the use of LTRAs at the doses generally recommended for asthma treatment Leonardi et al, 2007;Broshtilova and Gantcheva, 2010). In support, there is also the evidence that elevated levels of LTE 4 have been found in the urine of patients with AD (Adamek-Guzik et al, 2002;Øymar and Aksnes, 2005). Chronic urticaria (CU) may manifest as an idiopathic reaction or as a reaction to a known cause, such as cold, pressure, food additives, or NSAIDs; however, this does not occur with selective COX-2 inhibitors (Zembowicz et al, 2003).…”